Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Portfolio
  • Forum
  • Q&A
  • About Us
    • Our Coverage
    • Team
Research

Inderes Group - Q1: In line report, but market outlook taking step back - SEB

By SEB
Inderes
Download report (PDF)

Inderes posted a broadly in line Q1 report with sales slightly ahead (likely thanks to large AGMs in March) of SEBe. However, in rounded numbers, EBITA came in line with our estimate. While the March performance was better than expected our negative notes go to Sweden, where the company has seen churn in research contracts. Also, while the guidance remains unchanged, the company's market view is more cautious. We think a neutral reaction is warranted based on first read.

 

Outcome: Sales slightly ahead, EBITA in line

 

Inderes's Q1 sales came in at EUR 5.3m, topping our estimate of EUR 4.1m by -4%. As Jan-Feb sales were already reported the deviation owes to March sales, which saw 7% growth y/y while we had expected minor decline due to timing of AGMs. However, now the company notes that it has delivered large AGM packages. Also the Finnish event business had good month and software business continues its strong growth. The Q1 EBITA of EUR 0.5m was in line with our estimate, meaning the costs came in somewhat above our input. The higher materials and services costs are likely due to large AGM productions, we think. The international operations accounted for 20.5% of sales compared to 21.7% year ago. This implies flat y/y international revenue. Given that we think the revenue from other countries has increase slightly, the Swedish sales were still declining. 

The negative data point of the report is the number of commissioned research agreements which declined to 141 (vs. 145 year ago and 144 in the end-2024). Inderes explains the decline in the contract portfolio with acquisitions and some Swedish customers dissatisfaction research recommendations and target prices. 

Outlook: Guidance repeated, but more cautious view on markets for 2025

 

Inderes repeats its guidance for FY25 and expects its sales to grow from 2024 (EUR 18.4m) and EBITA margin to improve from the 2024 level (11.6%). We expect FY25 sales growth of 5% (EUR 20.2m) and EBITA margin of 12.1%. In its guidance background commentary Inderes takes a more cautious view on market development for 2025, expecting now that the target market will not grow in 2025. In its previous wording the company saw the market to remain flat or grow slightly in 2025.   

Conference call details: Finnish call starts at 9:30 EEST, English version at 2pm EEST

 

You can follow the Finnish webcast on Friday starting at 9:30 am EEST on 25 April 2025, at https://inderes.events.inderes.com/q1-interimreport-2025.

You can follow the English webcast on Monday starting at 2:00 pm EEST on 28 April 2025, at https://www.inderes.dk/videos/inderes-presentation-of-q1-2025.

Inderes

19.35EUR2025-04-24 18:00

Inderes operates in the financial industry. The company provides a community platform for investors and listed companies. Via the platform, users can communicate with each other and exchange investment tips. The customers consist of both companies and private individuals. In addition, the company offers analysis services and a basis for investment decisions. The largest operations are in the Nordic region.

Read more on company page
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Portfolio
  • Forum
  • Q&A
  • About Us
    • Our Coverage
    • Team